Adage Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Adage Capital Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14.3M	Buy	135,037 +122,037	+939%	+$13M	0.02%	529
2025 Q1	$1.61M	Buy	+13,000	New	+$1.61M	﹤0.01%	772
2022 Q4	–	Sell	-114,260	Closed	-$15.2M	–	1014
2022 Q3	$15.2M	Sell	114,260 -610,740	-84%	-$81.4M	0.04%	508
2022 Q2	$113M	Buy	725,000 +75,000	+12%	+$11.7M	0.26%	81
2022 Q1	$101M	Sell	650,000 -100,000	-13%	-$15.6M	0.19%	112
2021 Q4	$95.6M	Buy	750,000 +242,606	+48%	+$30.9M	0.17%	126
2021 Q3	$66.1M	Buy	507,394 +200,000	+65%	+$26M	0.13%	164
2021 Q2	$54.6M	Sell	307,394 -292,606	-49%	-$52M	0.11%	198
2021 Q1	$98.6M	Buy	600,000 +285,000	+90%	+$46.8M	0.2%	113
2020 Q4	$52M	Buy	315,000 +90,000	+40%	+$14.9M	0.11%	196
2020 Q3	$32.1M	Hold	225,000	–	–	0.08%	263
2020 Q2	$24.8M	Buy	+225,000	New	+$24.8M	0.06%	331
2018 Q3	–	Sell	-193,000	Closed	-$33.3M	–	734
2018 Q2	$33.3M	Sell	193,000 -156,189	-45%	-$26.9M	0.08%	288
2018 Q1	$52.7M	Sell	349,189 -119,186	-25%	-$18M	0.12%	210
2017 Q4	$63.1M	Buy	468,375 +143,375	+44%	+$19.3M	0.14%	181
2017 Q3	$47.5M	Sell	325,000 -325,000	-50%	-$47.5M	0.12%	233
2017 Q2	$101M	Sell	650,000 -575,000	-47%	-$89.4M	0.25%	109
2017 Q1	$178M	Buy	1,225,000 +500,000	+69%	+$72.6M	0.45%	49
2016 Q4	$79M	Buy	725,000 +475,000	+190%	+$51.8M	0.22%	131
2016 Q3	$30.4M	Buy	+250,000	New	+$30.4M	0.08%	313
2016 Q2	–	Sell	-50,000	Closed	-$6.53M	–	703
2016 Q1	$6.53M	Buy	+50,000	New	+$6.53M	0.02%	580
2014 Q4	–	Sell	-145,000	Closed	-$23.3M	–	735
2014 Q3	$23.3M	Buy	145,000 +3,000	+2%	+$482K	0.06%	358
2014 Q2	$20.9M	Buy	142,000 +42,000	+42%	+$6.17M	0.05%	388
2014 Q1	$13.9M	Buy	100,000 +45,000	+82%	+$6.24M	0.04%	451
2013 Q4	$6.96M	Buy	55,000 +30,000	+120%	+$3.8M	0.02%	561
2013 Q3	$2.3M	Sell	25,000 -310,000	-93%	-$28.5M	0.01%	633
2013 Q2	$23M	Buy	+335,000	New	+$23M	0.07%	328